Interleukin Genetics Inc

(NASDAQ:ILI)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 7,646 7,646 7,646 10,083
Cash At End Of Period 5,915 7,066 4,472 7,646
Net Change In Cash And Cash Equivalents -1,732 -581 -3,174 -2,436
Effect Of Exchange Rate Changes — — — —
Net Income Or Loss -5,183 -3,541 -1,875 -6,219
Cash From Operating Activities
Depreciation Expenses 1,216 805 402 1,983
Amortization Expenses — — — 457
Amortization Of Intangibles Expenses — — — —
Deferred Income Taxes 33 -3 -3 16
Operating Gains Or Losses — — — 44
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables 199 -225 -256 -22
Increase Or Decrease In Inventories 168 21 -2 505
Increase Or Decrease In Prepaid Expenses -9 -12 -53 100
Increase Or Decrease In Other Current Assets -9 -12 -53 100
Increase Or Decrease In Payables — — — —
Increase Or Decrease In Other Current Liabilities -198 17 350 -112
Increase Or Decrease In Other Working Capital -1,165 -997 -1,108 536
Other Non Cash Items — — — —
Net Cash From Continuing Operations 124 82 38 173
Net Cash From Discontinued Operations -4,815 -3,852 -2,507 -2,539
Net Cash From Operating Activities — — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — —
Sale Of Long Term Investments — — — —
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment -107 -23 -9 -39
Acquisitions -600 — -600 -63
Purchase Of Long Term Investments — — — —
Purchase Of Short Term Investments — — — —
Other Investing Changes Net -222 -715 -59 -213
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities -929 -738 -668 -315
Cash From Financing Activities
Issuance Of Debt 13 9 2 417
Issuance Of Capital Stock — — — —
Repayment Of Debt — — — —
Repurchase Of Capital Stock — — — —
Payment Of Cash Dividends — — — —
Net Other Financing Charges — — — —
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities 4,013 4,009 2 417